Takeda buys rights to Mersana's XMT-1522 outside USA and Canada

5 February 2016
2019_biotech_test_vial_discovery_big

Privately-held US biotech firm Mersana Therapeutics and Japan’s Takeda Pharmaceutical (TYO: 4502) have entered a new strategic partnership granting Takeda rights to Mersana’s lead product candidate, XMT-1522, outside the USA and Canada.

The deal also expands an existing collaboration between the companies to provide Takeda with additional access to Mersana’s Fleximer antibody-drug conjugate (ADC) platform (The Pharma Letter January 13) and grants Mersana an option at the end of Phase I to co-develop and co-commercialize one of these programs in the USA. In addition, the companies will co-develop new payloads for use with ADCs.

Financial terms

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Biotechnology